About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

NCT06545916·7 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Knoa Pharma LLC

With

Imbrium Therapeutics

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male and female age ≥18 years.
Diagnosis of moderate or severe alcohol use disorder.
Currently seeking treatment for alcohol use disorder.
Has 4 or more heavy drinking days (HDD) in each of the 4 weeks prior to baseline visit.

You may not be if

Subjects that meet current DSM-5 criteria for moderate or severe substance use disorder other than alcohol and nicotine.

The record

StatusCompleted

PhasePhase 2

Taking part209

StartedOct 2024

UpdatedJun 5, 2026

Conditions

Alcohol Use Disorder

Where7

Belmont Medical Office
Brooklyn, New York, United States
Ohio Clinical Trials
Columbus, Ohio, United States
Inquest Clinical Research
Baytown, Texas, United States

Clareo Health | Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder